SCHEMBL4198745

SCHEMBL4198745

C=C(C)C(=O)OC(COc1ccc(Oc2ccccc2)cc1)COc1ccc(-c2ccccc2OCC(COc2ccc(Oc3ccccc3)cc2)OC(=O)C(=C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 4/20 0.47
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGS2 P35354 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186157 0.94 L3MBTL1 (0.42) FFAR4TDP1L3MBTL1LMNAMAPK1
SCHEMBL4188675 0.93 MAPT (0.42) FFAR4TDP1L3MBTL1LMNAMAPK1
SCHEMBL4197498 0.93 MAPT (0.42) FFAR4TDP1L3MBTL1LMNAMAPK1
SCHEMBL4197860 0.93 L3MBTL1 (0.43) FFAR4TDP1L3MBTL1LMNAMAPK1
SCHEMBL4198416 0.90 MAPT (0.43) TDP1L3MBTL1LMNAMAPK1HTT
SCHEMBL4199988 0.90 ACACB (0.45) FFAR4LMNALTA4HFFAR1SMN1; SMN2
SCHEMBL4202644 0.89 L3MBTL1 (0.44) FFAR4TDP1L3MBTL1LMNAMAPK1
SCHEMBL4198738 0.89 FFAR4 (0.38) FFAR4HTTHSP90AA1HSP90AB1FFAR1
SCHEMBL19944473 0.88 LTA4H (0.47) LMNAHTTPPARGPPARALTA4H
SCHEMBL4197809 0.88 L3MBTL1 (0.48) TDP1L3MBTL1LMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 FFAR4 1889/4885TDP1 2459/4885L3MBTL1 2124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.